ProfileGDS5678 / 1426882_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 3% 3% 3% 4% 4% 3% 3% 3% 3% 3% 16% 4% 3% 3% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 11.987353
GSM967853U87-EV human glioblastoma xenograft - Control 21.979123
GSM967854U87-EV human glioblastoma xenograft - Control 31.984093
GSM967855U87-EV human glioblastoma xenograft - Control 41.969734
GSM967856U87-EV human glioblastoma xenograft - Control 51.97144
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 11.996563
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 21.979013
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.969763
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.957453
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.983013
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3793116
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.973454
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.975653
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.981813